Dermorphin-related peptides from the skin of Phyllomedusa bicolor and their amidated analogs activate two ,u opioid receptor subtypes that modulate antinociception and catalepsy in the rat ([Lys7] 
sites and suggested the existence of two receptor subtypes, of high and low affinity. The peptides tested acted as potent IA opioid agonists on isolated organ preparations. They were several times more active in inhibiting electrically evoked contractions in guinea pig ileum than in mouse vas deferens. When injected into the lateral brain ventricle or peritoneum ofrats, the high-affinity-site-preferring ligand, [Lys7-NH21dermorphin, behaved as a potent analgesic agent. By contrast, the low-affinitysite-preferring ligand, [Trp4,Asn7-NH2]dermorphin, produced a weak antinociception but an intense catalepsy.
Dermorphin is an opioid peptide (see peptide 1 in Table 1 ) isolated from the skin of South American frogs belonging to the subfamily Phyllomedusinae (1) . It has high affinity and selectivity for p. opioid receptors and produces analgesia in laboratory animals and humans (2) (3) (4) . By means of a cDNA library prepared from the skin of Phyllomedusa bicolor, the amino acid sequences of three dermorphin-like peptides were recently predicted (5) . These dermorphin analogs have now been isolated from methanol extracts of skin from this frog, and their amino acid sequences have been confirmed (15) . Like dermorphin, these peptides contain a D-alanine as the second amino acid and share the common amino-terminal sequence Tyr-DAla-Phe. The D-alanine present in the final products is encoded in the skin mRNA by a normal codon for L-alanine. While other opioid sequences in the frog skin precursors are all followed by a glycine residue required for the formation of terminal amides, this is not the case for these three dermorphin-like peptides. Accordingly, the end products extracted from the skin were found to contain a free a-carboxyl group at the carboxyl terminus. In the previous paper (5) the binding affinity and selectivity of these peptides for p. opioid receptors were briefly reported. In this paper, we present the binding profile to p., 8, and K opioid receptors and the biological activities of the Phyllomedusa bicolor dermorphin-like peptides, their related carboxyl-terminal amides, and a few substituted analogs.
MATERIALS AND METHODS Synthesis of Peptides. The peptides were synthesized by using fluorenylmethoxycarbonyl-polyamide active-ester chemistry on a Biolynx automated peptide synthesizer (Pharmacia Biochrom, Cambridge, U.K.). The products were purified by preparative HPLC on a Vydac reverse-phase column (22 x 250 mm, 10-,um particle size, 300-A pore diameter, C18 packing; The Separations Group) with a linear gradient from 1o to 90% of solvent B (5 mM trifluoroacetic acid in acetonitrile) in solvent A (5 mM trifluoroacetic acid in water) over 60 min. After hydrolysis in 6 M HCO (24 hr, 1100C, in vacuo), amino acid analyses gave ratios consistent with the desired structures. The expected amino acid sequences were confirmed by automated Edman degradation performed with an Applied Biosystems 470A protein sequencer.
Binding Assays. Binding of the peptides to p., 8, and K opioid sites was assayed in crude membrane preparations (6) from rat (p., 8) and guinea pig (K) brain at pH 7.4 in 50 mM Tris HCl buffer. Each assay mixture contained, in a final volume of 2 ml, the membrane preparation (0.8-1.0 mg of membrane proteins), protease inhibitors (100 puM phenylmethanesulfonyl fluoride, soybean trypsin inhibitor at 20 ,ug/ml, and bestatin at 10 pug/ml) ( 
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constants of the various nonradioactive peptides were calculated by fitting the displacement curves with the nonlinear regression program LIGAND (9), using one-site or two-site models. The results are given as mean ± SEM of at least six separate determinations. IC50 is the concentration of the competing ligand at which specific binding of labeled ligand is reduced by half. Kd and Ki are the equilibrium dissociation constants for the radioligand and inhibitor respectively, 1H is the slope of the log-logit plot of competition data, and B. is the maximum binding capacity of the radioligand. Because it is impractical to measure concentrations of unbound highaffinity unlabeled competing ligands, whenever an observed IC5o is less than the radioligand Kd, the computed value of K; may be too large by an indeterminate factor (8) .
Pharmacological Assays in Isolated Tissues. Preparations of the myenteric plexus-longitudinal muscle obtained from the small intestine of male guinea pigs (400-500 g) and preparations of mouse vas deferens were used for field stimulation with bipolar rectangular pulses of supramaximal voltage as described by Gyang and Kosterlitz (2) . Synthetic reference peptides were dermorphin (Farmitalia) for guinea pig ileum, and [DAla2jdeltorphin 1 (7) [Lys7]Dermorphin competition curve in the ,u opioid system of the rat brain. Data were fitted by the nonlinear regression program LIGAND. The solid line was the best fit for the two-site model, the broken line that for the one-site model. The apparent improvement in fit for the two-site model was significant (P < 0.01 versus one-site).
one (1 mg/kg of body weight) was administered to five-rat groups 15 min before i.c.v. injection of the peptides.
RESULTS
Binding Assay. (Fig. 3 ). An unexpected finding was that within few minutes of incubation with brain homogenates the biological activity of [Trp4,Asn7-NH2]dermorphin and to a lesser extent that of [Trp4]dermorphin was completely destroyed. Since both dermorphin and Tyr-DAla-Phe-Trp-Asn-NH2 were degraded slowly, the rapid cleavage of [Trp4,Asn7-NH2]dermorphin and [Trp4]dermorphin probably occurred between Trp4 and Tyr5. The mixture of inhibitors we used did not afford protection against this type ofenzyme degradation.
Biological Activity on Isolated Preparations. The peptides tested all acted as potent ,u opioid agonists on isolated organ preparations (Table 1) . They were several times more active in inhibiting electrically evoked contractions in guinea pig ileum than in mouse vas deferens. The rank order of their biological potencies roughly paralleled that of the respective ,u binding affinities. However, there were notable exceptions.
[Trp4,Asn7-NH2]dermorphin had twice the potency of [Lys7-NH2]dermorphin on guinea pig ileum, but one-third the affinity for ;L opioid receptors. [Trp4,Asn7]dermorphin had the same biological potency as [Lys7-NH2]dermorphin but a 1/20th the affinity for ,u opioid receptors.
Antinociception and Catalepsy. Peptides with a carboxylterminal amide group produced dose-related antinociceptive effects in rats (Table 2) Pharmacology: Negri et al. 
